GUO: Is that, like, the end of your company
Discontinuation rates due to adverse effects remain relatively low, with approximately 6% of Zepbound users and 8% of Wegovy users stopping treatment ^2
I couldnt believe myself, the dainty goth courting a gruff tradesman
Thomsen RW, Pedersen L, Mller N, Kahlert J, Beck-Nielsen H, Toft Srensen H
In comparison to placebo, liraglutide treatment reduced the prevalence of NAFLD by two-thirds, the amount of fat in the liver by 44%, visceral adipose tissue by 18%, and body weight by 5.2 kg (5.6%) (199)